B
rain edema formation after intracerebral hemorrhage (ICH) causes herniation-related death and severe neurological deficits. 1, 2 Although the mechanisms of edema formation after ICH are not fully determined, our previous study indicated that erythrocyte lysis and hemoglobin toxicity contribute to delayed brain edema. 3 Thus, an intracerebral injection of packed red blood cells (RBCs) into the caudate nucleus in a rat causes brain edema formation 3 days later, when the cells lyse. If the RBCs are lysed before injection, brain edema forms within 24 hours. 3 Hemolysate from erythrocyte lysis after subarachnoid hemorrhage contributes to cerebral vasospasm and ischemia. 4 Whether hemolysate causes vasospasm and cerebral ischemia after ICH is unknown, however. Indeed, whether ischemia contributes to brain edema formation after ICH remains controversial. For example, we found that the anatomic site of an intracranial hematoma may determine whether or not cerebral blood flow (CBF) is affected. 5 Hemoglobin and its degradation products (oxyhemoglobin, deoxyhemoglobin, or methemoglobin) can have adverse effects on the brain. Oxyhemoglobin is a spasminogen after subarachnoid hemorrhage. An intracortical injection of hemoglobin causes chronic focal spike activity and gliosis at the injection site. 6 Hemoglobin activates lipid peroxidation and kills neurons in culture. 7, 8 In addition, oxyhemoglobin can induce apoptosis in cultured endothelial cells, and apoptosis has been found in ICH. 9 -11 The aims of present study were to determine whether an intraparenchymal infusion of RBCs reduces perihematomal CBF and whether blood-brain barrier (BBB) disruption after the infusion contributes to brain edema formation.
Materials and Methods

Animal Preparation and Intracerebral Infusion
The protocols in this study were approved by the University of Michigan Committee on the Use and Care of Animals. Male Sprague-Dawley rats (nϭ87, Charles River Laboratories, Portage, Mich) weighing between 350 and 400 g were used in the experiments. Animals were anesthetized with pentobarbital (40 mg/kg IP). The right femoral artery was catheterized for blood pressure monitoring and blood sampling for ICH induction and blood gases. The rats were positioned in a stereotactic frame (Kopf Instruments), and a cranial burr hole (1.0 mm) was drilled in the skull (0.2 mm anterior, 5.5 mm ventral, 4.0 mm lateral to the bregma). Saline, packed RBCs, or lysed RBCs were microinfused into the right caudate nucleus at a rate of 10 L/min through a 26-gauge needle. 6 Controls for needle insertion received no infusion. To prepare packed RBCs, blood (0.5 mL) was centrifuged at 14 000g for 2 minutes, and the plasma and buffy coat were discarded. The RBCs were then washed 3 times in saline to obtain packed RBCs (hematocrit Ϸ86%). To prepare lysed RBCs, the packed cells were frozen in liquid nitrogen for 5 minutes and then allowed to thaw in containers immersed in water at room temperature.
Experimental Groups
This study was divided into 4 parts. In our previous studies, we found that 50 L of packed RBCs did not cause brain edema after 1 or 2 days but induced edema 3 days later. 3 We used 20-L injection volumes in this study rather than 50 L of lysed RBCs because preliminary studies showed that 6 of 6 rats died within 24 hours after intracerebral infusion of 50 L of lysed RBCs.
Brain Water and Sodium Contents
Rats were decapitated under deep pentobarbital anesthesia (60 mg/kg IP). The brains were immediately removed, and a 3-mm-thick coronal brain slice was cut (4 mm from the frontal pole). The slice was divided into 4 samples, ipsilateral and contralateral basal ganglia and ipsilateral and contralateral cortex. The cerebellum was also taken as control tissue distant from the site of injection. Tissue samples were weighed on an electronic analytical balance (model AE 100, Mettler Instrument Co) to the nearest 0.1 mg to obtain the wet weight (WW). The tissue was then dried at 100°C for Ͼ24 hours to determine the dry weight (DW). Tissue water contents (%) are calculated as [(WWϪDW)/WW]ϫ100. The dehydrated brain samples were digested in 1 mL of 1N nitric acid for 1 week. Sodium content was measured by flame photometry (Instrumentation Laboratory, Inc). Ion contents were expressed in microequivalents per gram of dehydrated brain tissue (Eq/g DW).
CBF Measurement
Rats were reanesthetized with pentobarbital, and CBF was determined. CBF was measured by the indicator fractionation technique 12 with [
14 C]N-isopropyl-p-iodoamphetamine ([ 14 C]IMP; American Radiolabeled Chemicals) as the blood flow marker. 13 This method uses an intravenous bolus injection of the blood flow indicator and a continuous rate (0.25 mL/min) of blood withdrawal through a femoral artery catheter to obtain the integral of the arterial isotope concentration. The withdrawals were started 5 seconds before the intravenous injection of 3 Ci of [
14 C]IMP and 10 Ci of [ 3 H]inulin, the latter used to measure cerebral plasma volume. Two minutes later, the animal was killed by decapitation, and blood withdrawal was stopped. The sample of withdrawn arterial blood was bleached with 30% H 2 O 2 before addition of scintillation fluid and determination of radiochemical content with a Beckman 3801 liquid scintillation counter. The brain was sampled as described above for brain edema measurements and digested in methylbenzethonium hydroxide before counting.
Blood flow rates for the individual pieces of brain tissue were calculated with the following equation:
where F b is brain blood flow, M b is brain mass (g), Q b (T) is quantity of indicator in the tissue at time T, F s is rate of blood withdrawal from tϭ0 to tϭT, and Q s (T) is quantity of indicator present in the withdrawal at time T. The CBF is expressed as mL · 100 g Ϫ1 · min Ϫ1 . 3 H]AIB injection, a peristaltic pump was started, and blood was withdrawn from an arterial cannula. At the end of the experiment, a terminal plasma sample was obtained, and the rat was killed by decapitation. The entire contents of the arterial cannula were emptied, and an aliquot was pipetted for counting. Blood samples were digested in methylbenzethonium hydroxide, bleached with H 2 O 2 , and counted in an aqueous-based liquid scintillation cocktail. Brain was sampled according to the earlier description of water content measurement. Brain tissue was also digested in methylbenzethonium hydroxide and counted. The influx rate constant (K i ) for [ 3 H]AIB was calculated from the following formula: 
BBB Permeability
(2) K i ϭ[C br Ϫ(CPVϫC t )]/(͐C p ϫdt) ,
Results
For brain water content and BBB measurements, blood pH (7.48Ϯ0.04), glucose (6.1Ϯ1.0 mmol/L), hematocrit (40Ϯ2%), PO 2 (78Ϯ5 mm Hg), PCO 2 (42Ϯ5 mm Hg), and blood pressure (112Ϯ11 mm Hg) were in the normal range. During measurements of the CBF, there were no significant differences in the physiological parameters among any of the groups (Table 1) .
Brain Water Content
Twenty-four hours after intracerebral infusion, brain water contents in the ipsilateral basal ganglia were 84.7Ϯ0.2%, 78.7Ϯ0.8%, and 79.1Ϯ0.3% for the lysed RBCs, packed RBCs, and saline groups, respectively. The marked edema formation in the lysed RBC group (PϽ0.01 versus other 2 groups) was associated with a marked (PϽ0.01) increase in brain sodium content (sodium contents were 659Ϯ102, 200Ϯ14, and 229Ϯ19 Eq/g DW for the lysed RBCs, packed RBCs, and saline groups, respectively). There were no differences in water or sodium contents in contralateral tissues or the cerebellum between the various groups of animals.
Cerebral Blood Flow
Although intracerebral infusion of lysed RBCs was associated with marked ipsilateral edema, it did not reduce CBF to levels expected to cause ischemic brain damage in the ipsilateral basal ganglia or cortex (Figure 1 ). Blood flows in the ipsilateral basal ganglia were 53Ϯ7, 49Ϯ3, and 37Ϯ17 mL · 100 g Ϫ1 · min Ϫ1 in the sham, packed RBC, and lysed RBC groups, respectively, 24 hours after intracerebral infusion. CBF in the ipsilateral basal ganglia was decreased significantly (PϽ0.05) at 2 hours after infusion of lysed RBCs, but this reduction was again modest (45Ϯ7 versus 62Ϯ12 mL · 100 g Ϫ1 · min Ϫ1 in shams). To test lysis of RBCs in vivo, packed RBCs were injected into the right basal ganglia, and CBF levels were measured 72 hours later. Packed RBCs failed to reduce CBF at 72 hours in either the ipsilateral basal ganglia (64Ϯ24 versus 55Ϯ10 mL · 100 g
Ϫ1
· min
Ϫ1 in sham control) or the ipsilateral cortex (72Ϯ26 versus 54Ϯ9 mL · 100 g Ϫ1 · min Ϫ1 in sham control) ( Figure 2 ). Figure 3 ). There was also an increase in the ipsilateral cortex ( Figure 3) . In contrast, an infusion of packed RBCs did not cause an increase in the [ 3 H]AIB influx rate constant at 24 hours in the ipsilateral basal ganglia or cortex (Figure 3 Figure 4A ) and 3-fold higher in the ipsilateral cortex than in the contralateral cortex.
BBB Permeability
The AIB influx rate constants for the lysed RBC rats were recalculated, with the average 20-second inulin spaces used to correct for cerebral plasma volume. The influx rate constant in the ipsilateral basal ganglia was 8.25Ϯ1.93 L · g Ϫ1 · min
Ϫ1
(compared with the 7.93Ϯ1.87 L · g Ϫ1 · min Ϫ1 when corrected with data from a 2-minute inulin space), whereas that in the contralateral basal ganglia was 1.94Ϯ0.34 L · g
· min
Ϫ1 (compared with 1.95Ϯ0.31 L · g Ϫ1 · min Ϫ1 when corrected with data from a 2-minute inulin space), a 4-fold increase.
In (Table 2) , but there was a marked increase in the influx rate constant for [ 14 C]inulin in the ipsilateral basal ganglia and cortex ( Figure 4B ).
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Discussion
Our present studies indicate that although an intracerebral infusion of RBC hemolysate induces marked edema, CBF in the vicinity remains close to normal. Rather than ischemic damage, it appears that the edema formation is related to marked BBB disruption from the toxic effect of lysed RBCs. Such disruption occurred in response to artificially lysed RBCs or natural lysis after the infusion of packed RBCs.
Whether ischemia contributes to brain edema formation after ICH and if so how much remains controversial. Experiments have shown that CBF adjacent to a hematoma decreases. Perihematomal CBF falls below 25 mL · 100 g Ϫ1 · min Ϫ1 , 16 but the reduction lasts Ͻ10 minutes and returns to baseline within 3 hours. 17 Previous work in our laboratory also showed that a 50% reduction of CBF develops around the hematoma only during the first hour and returns to control levels within 4 hours. 18 Generally speaking, the CBF threshold for ischemic injury is 15 to 20 mL · 100 g Ϫ1 · min Ϫ1 . 19 These results indicate that critical levels and durations of hypoperfusion do not occur after experimental ICH and that perihematomal brain edema is not associated with cerebral ischemia, at least with hematomas of the size used in this study. Recently, Wagner et al 20 measured ATP and phosphocreatine levels in the perihematomal edema zone at 1, 3, 5, and 8 hours after ICH. Although severe brain edema was present around the hematoma at all time points, ATP levels remained in the normal range and brain phosphocreatine contents increased with time, indicating that an energy deficit was not present around the hematoma. Interestingly, Qureshi et al 21 reported that an ischemic penumbra is not present around the clot in a canine ICH study.
In humans, Mayer et al, 22 using single photon emission computed tomography (SPECT), investigated perihematomal CBF. An early hypoperfusion zone was found around the hematoma, with resolution by 48 hours. Because this low-CBF zone was correlated with a perihematomal edema rim, they suggested that reperfusion injury might contribute to edema formation. CBF reduction was also reported by Tanaka et al. 23 In a positron emission tomography (PET) study, however, Diringer et al 24 could not find secondary ischemic brain injury after ICH in 12 patients. Using diffusion-weighted MRI and proton magnetic resonance spectroscopic imaging, Carhuapoma et al 25 reported that widespread ischemia was not found around the hematoma. Most recently, Zazulia et al 26 measured perihematomal CBF, cerebral metabolic rate of oxygen, and oxygen extraction fraction in 19 ICH patients with PET. They found that both cerebral metabolic rate of oxygen and CBF were reduced in the perihematomal zone, resulting in reduced oxygen extraction fraction. Thus, an apparent reduction in CBF may result from reduced metabolism around the clot.
Some of the differences in CBF data between patients and animal models may be due to the absolute volume of the hematoma. First, the average hematoma size in humans is Ϸ30 to 40 mL, whereas in the animal models, the hemorrhage volume is proportionately smaller. For example, a 50-L clot in a rat or a 2-mL clot in a piglet corresponds to a 30-mL clot in a human. Second, measurement of the hematoma volume from CT scans is complex. 27 Reports show that the hematocrit in the clot may be as high as 90% because of clot retraction. 28 Hence, the initial hemorrhage volume may be greater than the hematoma size shown by CT.
The anatomic localization of an intracranial hematoma is a major factor affecting CBF. Patel et al 5 injected equal volumes of blood into the subdural space or into the caudate nucleus of rats. They measured CBF by [ 14 C]iodoantipyrine autoradiography, infarct volume by TTC staining, and brain edema. Subdural hemorrhage induced significant reductions in CBF, but ICH alone induced a modest reduction in CBF around hematoma. Ischemic brain injury was observed in the cerebral cortex after subdural hemorrhage, but minimal perihematomal infarct was detected after ICH. Although ICH did not cause marked brain ischemia, it did induce significant brain edema.
Although it is generally accepted that reductions in CBF of ϾϷ70% are necessary to induce ischemic brain damage, some recent evidence suggests that more modest reductions (Ϸ60%) may cause delayed neuronal death. 29 This may raise the question of whether the modest reduction (30%) in CBF with lysed erythrocytes might cause some brain injury. It should be noted, however, that infusion of lysed erythrocytes causes very marked edema formation (85% water content in the ipsilateral basal ganglia) within 24 hours. This edema is similar to the 85% water content that occurs in the core of the infarct after 24 hours of middle cerebral artery occlusion, where CBF is reduced by Ϸ80%. 14 Thus, because of timing and magnitude, it is very unlikely that such lysate-induced edema could result from the observed change in CBF. It should also be noted that the study by Zazulia et al 26 on human ICH patients suggests that modest declines in CBF may reflect a decline in metabolism around the clot.
Rather than ischemia, perihematomal edema development may involve damage to the vascular endothelium. Iron is a potent catalyst of lipid peroxidation, and the release of iron (a breakdown product of hemoglobin) after erythrocyte lysis may contribute to BBB dysfunction. It has also been shown that oxyhemoglobin can induce apoptosis in cultured endothelial cells, possibly through free radical damage to the endothelial vessel wall tissue. 9 The temporal pattern of edema formation after infusion of lysed or packed erythrocytes is similar to the pattern of BBB disruption. 3 A second mechanism that might contribute to edema development after erythrocyte lysis is direct damage to neurons and astrocytes involved in maintaining extracellular homeostasis. Intracortical infusion of lysed blood but not unlysed blood induced strong expression of heat shock protein 70, a neuronal injury marker, in both ipsilateral and contralateral neocortex and hippocampus. 30 Exposure of cultured rat spinal cord cells to hemoglobin produces concentration-dependent cell toxicity, which can be measured by lactate dehydrogenase release. 8 Hemoglobin may induce brain injury via its degradation products, because our previous studies indicate that such products play a major role in the formation of brain edema. 31 Thrombin has been implicated in brain injury and edema formation after ICH. [32] [33] [34] Most attention has focused on thrombin formation during clotting. The fact that erythrocyte lysis causes marked BBB disruption, even to large molecules such as inulin, however, suggests that there may be a significant entry of prothrombin into the brain after erythrocyte lysis. If activated factor X is present, either because of the entry of factor X from the blood or through expression of factor X by brain parenchymal cells, 35 an influx of prothrombin will result in the generation of thrombin within the brain, which may also induce edema formation.
Intracerebral injection of thrombin also causes BBB disruption. Infusion of 5 U of thrombin, a dose that causes marked cerebral edema, however, causes only an Ϸ50% increase in BBB [ 3 H]AIB permeability, compared with the 300% increase caused by lysed RBCs. 15 In a time-course study of BBB disruption after ICH, Yang et al 18 found only a modest increase in BBB at 12 and 24 hours but a more marked increase at 2 days. Their data may reflect the difference in the capacity of thrombin and erythrocyte lysis to disrupt the BBB. The increase in BBB [ 3 H]AIB permeability after intracerebral infusion of lysed RBCs is also greater than that which occurs in focal cerebral ischemia, in which increases of 70% to 100% occur 24 hours after middle cerebral artery occlusion in the rat. 14, 36 Similarly, we found that BBB inulin permeability is increased by a factor of 3 at 6 hours after middle cerebral artery occlusion, compared with an 11-fold increase induced by lysed RBCs reported in this study. 37 Because the adverse effect of an ICH seems to result from a "toxic" effect of blood components on the brain, the question arises as to whether clot removal is the best therapeutic strategy, because it would result in the removal of all the toxic components. Six randomized trials have been carried out, but clot evacuation by surgery remains controversial. 38 -43 Recently, Wagner et al 44 infused tissue plasminogen activator (tPA) into hematomas in a pig model at 3 hours after induction and aspirated the liquified clots 1 hour later. Clot removal after tPA treatment resulted in a 72% reduction in hematoma volume compared with unevacuated controls. Clot removal also reduced brain edema volume and BBB disruption and improved cerebral tissue pressure. Thus, early and complete hematoma removal, which prevents the contribution of erythrocyte lysis to an already edematous brain, may be beneficial.
We conclude that a cascade of events triggered by erythrocyte lysis is critical for the delayed development of edema after ICH. Cerebral ischemia does not play a significant role in edema formation after ICH. Rather, edema formation results from a toxic effect of RBCs and/or hemoglobin breakdown products, with BBB disruption contributing to increased cerebral water content in the region of the hemorrhage. Erythrocyte-induced BBB disruption and edema formation after ICH are delayed and should therefore be susceptible to therapeutic modification. Such therapies should focus on preventing hemoglobin-induced toxicity rather than ischemia.
